Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.
Laurence LegrosFranck E NicoliniGabriel EtiennePhilippe RousselotDelphine ReaStéphane GiraudierAgnès Guerci-BreslerFrançoise HuguetMartine GardembasMartine EscoffreJean-Christophe IanottoMarie-Pierre NoëlBruno R VaretThomas PagliardiniIrit TouitouStéphane MorissetFrancois-Xavier Mahonnull nullPublished in: Cancer (2017)
This study is the first to demonstrate that a second TKI discontinuation attempt is safe and that a first failed attempt at discontinuing TKI does not preclude a second successful attempt. Cancer 2017;123:4403-10. © 2017 American Cancer Society.